GC Wealth Management RIA’s Pfizer PFE Stock Holding History

GC Wealth Management RIA’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$336K	Sell	13,942 -309	-2%	-$8.08K	0.02%	396
2026 Q1	$400K	Sell	14,251 -4,205	-23%	-$112K	0.02%	384
2025 Q4	$460K	Sell	18,456 -48,783	-73%	-$1.23M	0.02%	376
2025 Q3	$1.71M	Buy	67,239 +43,227	+180%	+$1.07M	0.06%	236
2025 Q2	$582K	Buy	24,012 +7,611	+46%	+$177K	0.05%	291
2025 Q1	$416K	Sell	16,401 -2,955	-15%	-$77.3K	0.08%	206
2024 Q4	$514K	Sell	19,356 -2,646	-12%	-$71.8K	0.09%	169
2024 Q3	$637K	Sell	22,002 -3,549	-14%	-$104K	0.11%	161
2024 Q2	$715K	Sell	25,551 -11,367	-31%	-$313K	0.14%	130
2024 Q1	$1.02M	Buy	36,918 +1,453	+4%	+$40.3K	0.21%	98
2023 Q4	$1.02M	Buy	+35,465	New	+$1.07M	0.46%	60

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GC Wealth Management RIA's PFE Position: Q2 2026 in Review

GC Wealth Management RIA reduced its Pfizer (PFE) stake by 2.2% in Q2 2026, selling an estimated $8.08K and leaving 13,942 shares worth $336K. The position accounts for 0.02% of the portfolio, ranked #396.

GC Wealth Management RIA first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.71M in Q3 2025. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

GC Wealth Management RIA held 13,942 shares of Pfizer worth $336K as of Q2 2026.
GC Wealth Management RIA sold 309 Pfizer shares in Q2 2026, an estimated $8.08K.
Pfizer made up 0.02% of GC Wealth Management RIA's portfolio in Q2 2026, its #396 holding.
GC Wealth Management RIA first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
GC Wealth Management RIA's Pfizer position peaked at $1.71M in Q3 2025.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on GC Wealth Management RIA's 13F filing for Q2 2026, filed 16 Jul 2026.